Beranda › Gangguan Depresi Mayor › Utah
Uji klinis Gangguan Depresi Mayor di Utah
14 studi untuk Gangguan Depresi Mayor mencari peserta di lokasi di Utah.
Kota di Utah
Teks studi resmi (Bahasa Inggris)
A Study of Brenipatide (LY3537031) in Adult Participants With Major Depressive Disorder
- Boeson Research - Provo, Provo
Menerima pesertaFase 3
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT07775300A Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive Disorder
- Alpine Research Organization, Clinton
Menerima pesertaFase 3
Usia 18 hingga 74 · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT07573176A Study to Evaluate TNX-102 SL Monotherapy Versus Placebo in Participants With Major Depressive Disorder (MDD)
- Boeson Research Pvu, Provo
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT07621237A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder (X-NOVA3)
- Boeson Research, Provo
Menerima pesertaFase 3
Usia 18 hingga 74 · Semua jenis kelamin · Diperbarui 8 Sep 2026 · NCT07076407Treatment ResistAnt Depression Subcallosal CingulatE Network DBS (TRANSCEND)
- University of Utah Hospital, Salt Lake City
Menerima peserta
Usia 22 hingga 70 · Semua jenis kelamin · Diperbarui 28 Agu 2026 · NCT064234305-HTP and Creatine for Depression R33 Phase
- University of Utah Department of Psychiatry, Salt Lake City
Menerima pesertaFase 2
Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 27 Agu 2026 · NCT05895747A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)
- Cedar Clinical Research, Draper
- Inner Space Research, Orem
Menerima pesertaFase 3
Usia 18 hingga 74 · Semua jenis kelamin · Diperbarui 10 Agu 2026 · NCT07592689A Study of Brenipatide in Adult Participants With Major Depressive Disorder
- Alpine Research Organization, Clinton
Menerima pesertaFase 3
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 6 Agu 2026 · NCT07412756Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder
- Andes Clinical Research, Orem
Menerima pesertaFase 2
Usia 18 hingga 64 · Semua jenis kelamin · Diperbarui 3 Agu 2026 · NCT06547489A Study to Evaluate the Maintenance Effect of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Neurocrine Clinical Site, Draper
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 24 Jul 2026 · NCT07196501A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)
- Cedar Clinical Research Inc, Draper
Menerima pesertaFase 2
Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 11 Mei 2026 · NCT06524830Study of ABX-002 for the Adjunctive Treatment of Major Depressive Disorder (AMPLIFY)
- Autobahn Site #159, Orem
Menerima pesertaFase 2
Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 20 Jan 2026 · NCT06633016Mechanisms of Rumination Change in Adolescent Depression
- University of Utah, Salt Lake City
Menerima peserta
Usia 14 hingga 17 · Semua jenis kelamin · Diperbarui 11 Agu 2025 · NCT03859297Study of ALTO-300 in MDD
- Site 207, Clinton
Menerima pesertaFase 2
Usia 18 hingga 70 · Semua jenis kelamin · Diperbarui 24 Jul 2025 · NCT05922878Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.